Sort by
Refine Your Search
-
, stem cell biology, and colon cancer. Position Status Full Time Posting Number 26FA0353 Posting Open Date 04/14/2026 Posting Close Date Qualifications Minimum Education and Experience PhD training is
-
biomedical science. Consideration to interview will also be given to applicants who are in the process of completing their PhD or equivalent doctorate degree in Cancer Biology, Precision Cancer Medicine, or a
-
and Experience PhD, MD, or equivalent doctoral degree in Neuroscience, Biomedical Engineering, Computer Science, or a related field. Candidates in ABD (all but degree) status will also be considered
-
Pension Eligibility ABP Qualifications Minimum Education and Experience PhD, MD, or equivalent doctoral degree in Neuroscience, Biomedical Engineering, Computer Science, or a related field. Candidates in
-
letter, CV, and the names and contacts of three references. Questions should be directed to: Wei-Xing Zong, PhD, Department of Chemical Biology, the Cancer Institute of New Jersey, Rutgers University, 164
-
Posting Number 26FA0195 Posting Open Date Posting Close Date Qualifications Minimum Education and Experience PhD degree in Chemistry, Medicinal Chemistry, Biochemistry, or Pharmacology at the time of
-
month Position Pension Eligibility ABP Qualifications Minimum Education and Experience The candidate must have a PhD in the fields of Neuroscience or Cell Biology, and must have a strong background in
-
Salaried Payroll Designation PeopleSoft Seniority Unit Terms of Appointment Staff - 12 month Position Pension Eligibility ABP Qualifications Minimum Education and Experience PhD degree in Neuroscience
-
are in compliance with the necessary trainings (both at the lab and at the institutional level). Minimum Education and Experience: A PhD degree in Computer Science, Electrical/Computer Engineering, or a
-
current research, occurring in priority areas such as: (1) Maternal Morbidity and Child Health, (2) Quality of Health and Healthcare, (3) Mental Health Access and Care, (4) Health Equity and (5) COVID-19